| By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma | |
| Li, Sainan; Dai, Weiqi; Mo, Wenhui; Li, Jingjing; Feng, Jiao; Wu, Liwei; Liu, Tong; Yu, Qiang; Xu, Shizan; Wang, Wenwen | |
| 刊名 | INTERNATIONAL JOURNAL OF CANCER
 |
| 2017 | |
| 卷号 | 141期号:12 |
| 关键词 | combination treatment cell metabolism glycolysis mitochondrial apoptosis |
| ISSN号 | 0020-7136 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3612612 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Li, Sainan,Dai, Weiqi,Mo, Wenhui,et al. By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma[J]. INTERNATIONAL JOURNAL OF CANCER,2017,141(12). |
| APA | Li, Sainan.,Dai, Weiqi.,Mo, Wenhui.,Li, Jingjing.,Feng, Jiao.,...&Guo, Chuanyong.(2017).By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma.INTERNATIONAL JOURNAL OF CANCER,141(12). |
| MLA | Li, Sainan,et al."By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma".INTERNATIONAL JOURNAL OF CANCER 141.12(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论